(Q80206172)
Statements
Phase I/II trial of a P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), given orally in combination with the CHOP regimen in patients with non-Hodgkin's lymphoma (English)
Franck Morschhauser
Michael Burgess
Lisette Sloots
Fadela Bouafia
1 April 2007